Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
CellaVision AB is a Sweden-based medical technology company specializing in digital hematology microscopy solutions. Established in 1994 and headquartered in Lund, Sweden, it develops and sells advanced analyzers, staining reagents, smearing and staining devices, and software to automate cell classification and analysis in laboratories worldwide. With over 250 employees, market support offices in 12 to 16 markets, and a presence in more than 40 countries, CellaVision manufactures reagents in-house in Martillac, France, while outsourcing analyzer production in Sweden. The company leverages deep learning and artificial intelligence to enhance laboratory workflows, minimize human error, and improve diagnostic certainty for human and animal blood and body fluid samples. Its mission focuses on advancing laboratory efficiency and healthcare through intelligent microscopy, with notable achievements including over 30 years of experience and more than 8,000 units sold. CellaVision plays a pivotal role in the medical diagnostic equipment sector by standardizing processes, fostering collaboration, and elevating global hematology standards.